Radiopharm Theranostics Limited (RADX)

NASDAQ: RADX · Real-Time Price · USD

4.795

+0.075 (1.59%)

At close: Mar 20, 2026, 4:00 PM EDT

5.05

+0.26 (5.32%)

After-hours: Mar 20, 2026, 4:27 PM EDT

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
The Research, Development and Commercialisation of Health Technologies	12.51M	1.96M	6.21M	8.83K
The Research, Development and Commercialisation of Health Technologies Growth	538.86%	-68.46%	70218.68%	-
Total	12.51M	1.96M	6.21M	8.83K
Total Growth	538.86%	-68.46%	70218.68%	-

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
United States	3.63M	299.23K	292.36K	-
United States Growth	1114.27%	2.35%	-	-
Australia	-	-	-	8.83K
Total	3.63M	299.23K	292.36K	8.83K
Total Growth	1114.27%	2.35%	3210.60%	-

Source: S&P Global Market Intelligence.